Table 2

Logistic regression models with ORs and coefficients from validation data sets

Unit of changeSpline knotModel 1: BG≤70 mg/dLModel 2: BG<54 mg/dL
OR (95% CI)CoefficientOR (95% CI)Coefficient
Intercept2.1400.580
Age10 years
 Age1≤401.07 (0.96 to 1.20)0.066
 Age2>400.96 (0.92 to 0.99)−0.045
Female0.76 (0.66 to 0.86)−0.280
Weight10 kg
 Weight1≤800.87 (0.84 to 0.91)−0.1360.85 (0.80 to 0.91)−0.160
 Weight2>800.92 (0.90 to 0.95)−0.0790.86 (0.81 to 0.91)−0.151
Admission to surgical service0.91 (0.85 to 0.98)−0.091
Basal insulin dose0.1 units/kg
 Basal1≤0.21.85 (1.75 to 1.97)0.6172.01 (1.79 to 2.25)0.697
 Basal2≤0.81.14 (1.10 to 1.17)0.1301.15 (1.09 to 1.21)0.141
 Basal3≤1.30.95 (0.85 to 1.06)−0.0500.95 (0.80 to 1.14)−0.046
 Basal4≤1.61.29 (0.92 to 1.78)0.2491.84 (1.15 to 2.95)0.609
 Basal5>1.60.95 (0.71 to 1.28)0.7550.29 (0.07 to 1.28)−1.238
Nutritional insulin dose0.1 units/kg
 Nutritional1≤0.61.05 (1.02 to 1.08)0.0481.05 (1.00 to 1.10)0.049
 Nutritional2≤0.91.05 (0.90 to 1.23)0.0481.04 (0.80 to 1.33)0.035
 Nutritional3≤1.10.59 (0.36 to 0.94)−0.5340.51 (0.22 to 1.17)−0.674
 Nutritional4>1.11.07 (0.86 to 1.35)0.0711.19 (0.86 to 1.65)0.176
Correctional insulin dose0.1 units/kg
 Correctional1≤0.040.69 (0.49 to 0.97)−0.365
 Correctional2≤0.71.04 (0.99 to 1.10)0.041
 Correctional3≤0.90.71 (0.39 to 1.30)−0.336
 Correctional4>0.91.17 (0.79 to 1.72)0.159
High-dose SSI1.14 (1.03 to 1.27)0.1351.18 (0.97 to 1.45)0.169
Index day mean BG10 mg/dL
 Mean1≤1000.73 (0.64 to 0.83)−0.3120.80 (0.66 to 0.97)−0.220
 Mean2≤1500.86 (0.83 to 0.89)−0.1550.89 (0.84 to 0.94)−0.122
 Mean3>1500.99 (0.97 to 1.01)−0.0111.03 (1.01 to 1.05)0.030
Index day nadir BG10 mg/dL
 Nadir1≤880.99 (0.95 to 1.03)−0.0110.91 (0.85 to 0.97)−0.099
 Nadir2≤1000.64 (0.58 to 0.71)−0.4400.80 (0.66 to 0.96)−0.228
 Nadir3>1000.93 (0.91 to 0.95)−0.0700.93 (0.89 to 0.96)−0.076
Index day CV of BG10%
 CV1≤100.93 (0.61 to 1.42)−0.0771.04 (0.44 to 2.47)0.035
 CV2≤201.72 (1.46 to 2.02)0.5411.51 (1.10 to 2.09)0.417
 CV3>201.01 (0.96 to 1.05)0.0061.02 (0.94 to 1.10)0.017
Admission nadir BG10 mg/dL
 Admission nadir1≤1000.87 (0.86 to 0.89)−0.1340.86 (0.83 to 0.90)−0.147
 Admission nadir2≤4001.03 (1.01 to 1.05)0.0291.04 (1.00 to 1.07)0.035
 Admission nadir3>4000.84 (0.58 to 1.19)−0.1800.88 (0.63 to 1.24)−0.122
Admission CV of BG10%
 Admission cv1≤180.78 (0.63 to 0.96)−0.2490.73 (0.49 to 1.09)−0.311
 Admission cv2>181.19 (1.14 to 1.24)0.1711.17 (1.10 to 1.25)0.159
Diet orders
 NPO1.00 (ref)1.00 (ref)
 Carbohydrate-controlled0.80 (0.71 to 0.92)−0.2180.67 (0.53 to 0.84)−0.406
 Regular or other0.79 (0.72 to 0.86)−0.2350.69 (0.59 to 0.81)−0.373
 Bolus tube feeds0.68 (0.54 to 0.86)−0.3820.76 (0.51 to 1.15)−0.268
Type 1 diabetes/pancreatectomy1.43 (1.28 to 1.59)0.3572.04 (1.73 to 2.39)0.712
Type 2 diabetes1.25 (1.13 to 1.38)0.2241.29 (1.07 to 1.55)0.253
AKI1.27 (0.99 to 1.63)0.238
CKD
 None1.00 (ref)1.00 (ref)
 Stage 31.25 (1.15 to 1.37)0.2241.37 (1.16 to 1.61)0.314
 Stage 41.52 (1.37 to 1.69)0.4181.80 (1.49 to 2.17)0.588
 Stage 51.76 (1.56 to 1.99)0.5652.21 (1.80 to 2.73)0.795
Liver disease0.70 (0.48 to 1.01)−0.363
Digestive disease1.20 (1.04 to 1.39)0.184
Steroids on index day0.84 (0.74 to 0.96)−0.170
  • Bolded values signify P<0.05.

  • AKI, acute kidney; BG, blood glucose; CKD, chronic kidney disease; CV, coefficient of variation; NPO, nil per os; ref, reference; SSI, sliding scale insulin.